FindMyRecallSubscribe
Class I: serious health riskTerminated

Shoreside Enterprises 7K capsules packaged in single packs sold in Recall

7K capsules packaged in single packs sold in 24-count boxes, Distributed by SX Power Co

Shoreside Enterprises Inc. · Tampa, FL

Risk level
Class I
Reported by FDA
Jun 6, 2018
Recall ID
D-0880-2018
Check your lot numberHow we source this data

Summary

Shoreside Enterprises recalled 7K capsules packaged in single packs sold in starting May 17, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0880-2018 on Jun 6, 2018. Reason: Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Product description

7K capsules packaged in single packs sold in 24-count boxes, Distributed by SX Power Co. San Diego, CA 92108, UPC 601577513148

Lot numbers, UPCs & expiration codes

Lot #: RO, Exp. 12/31/2021

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0880-2018
Classification
Class I
Status
Terminated
Recall initiated
May 17, 2018
FDA report date
Jun 6, 2018
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Shoreside Enterprises Inc.

Original FDA data

Every field from FDA enforcement report D-0880-2018, exactly as published.

Show all FDA fields
City
Tampa
State
FL
Status
Terminated
Country
United States
Event ID
80128
Address
6345 Newtown Cir Apt A3 Ste A-3
Code information
Lot #: RO, Exp. 12/31/2021
Postal code
33615-3629
Report date
Jun 6, 2018
Product type
Drugs
Recall number
D-0880-2018
Classification
Class I
Recalling firm
Shoreside Enterprises Inc.
Product quantity
Unknown
Termination date
Jun 10, 2020
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Voluntary / mandated
Voluntary: Firm initiated
Product description
7K capsules packaged in single packs sold in 24-count boxes, Distributed by SX Power Co. San Diego, CA 92108, UPC 601577513148
Distribution pattern
Nationwide.
Recall initiation date
May 17, 2018
Initial firm notification
Press Release
Center classification date
Jun 18, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0880-2018, published Jun 6, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls